{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:20:04Z","timestamp":1767990004082,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China for Distinguished Young Scholars","award":["82125004"],"award-info":[{"award-number":["82125004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hypertrophic cardiomyopathy (HCM) is the common cause of sudden cardiac death in young people and is characterized by cardiac hypertrophy. Non-HCM caused left ventricular hypertrophy (LVH) is more common in the population, especially in people with hypertension, obesity, and diabetes. In order to identify high-risk populations, a screening technique that can rapidly differentiate between HCM and LVH patients should be developed. Plasma metabolomics may help develop useful biomarkers for the disease diagnosis. We performed a comprehensive plasma metabolomic analysis on a total of 720 individuals, included 441 HCM patients, 160 LVH patients, and 119 normal controls (NC) (derivation cohort\u2009=\u2009368, validation cohort\u2009=\u2009352). Orthogonal partial least squares discriminant analysis (OPLS-DA) was used to construct discriminant models based on metabolomics, and the result showed significant changes in plasma metabolic profiling among the HCM, LVH, and NC. The prospective diagnostic biomarkers for HCM patients have been examined using variable importance in projection, fold change, and FDR. Acylcarnitines efficiently distinguished HCM and LVH patients, with a C14:0-carnitine AUC of 0.937 shown by the reiver operator characteristic (ROC) curve analysis. The biomarkers for the diagnosis of HCM patients was verified in another independent validation cohort. This study is the largest plasma metabolomics analysis of Chinese Han patients with HCM, finding biomarkers that can be used to distinguish between HCM from LVH patients. These results highlight the great potential value of plasma metabolic profiling analysis on HCM diagnoses.<\/jats:p>","DOI":"10.1186\/s40364-025-00768-0","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T15:05:06Z","timestamp":1743865506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy"],"prefix":"10.1186","volume":"13","author":[{"given":"Hao","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumeng","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"7","key":"768_CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian AJ, Braunwald E. Hypertrophic cardiomyopathy. Circul Res. 2017;121(7):749\u201370.","journal-title":"Circul Res"},{"issue":"17","key":"768_CR2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2021.03.008","volume":"77","author":"H Cui","year":"2021","unstructured":"Cui H, Schaff HV, Lentz Carvalho J, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Lee AT, Bos JM, Ackerman MJ, Ommen SR, Maleszewski JJ. Myocardial histopathology in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2021;77(17):2159\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"768_CR3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0735-1097(01)01778-8","volume":"39","author":"MJ Eriksson","year":"2002","unstructured":"Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638\u201345.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"768_CR4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jacc.2024.07.043","volume":"84","author":"HS Lumish","year":"2024","unstructured":"Lumish HS, Sherrid MV, Janssen PML, Ferrari G, Hasegawa K, Castillero E, Adlestein E, Swistel DG, Topkara VK, Maurer MS, Reilly MP, Shimada YJ. Comprehensive proteomic profiling of human myocardium reveals signaling pathways dysregulated in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2024;84(20):1999\u20132011.","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"768_CR5","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J. 2014;35(39):2733\u201379.","journal-title":"Eur Heart J"},{"issue":"16","key":"768_CR6","first-page":"1952","volume":"135","author":"L Guo","year":"2022","unstructured":"Guo L, Wang B, Zhang F, Gao C, Hu G, Zhou M, Wang R, Zhao H, Yan W, Zhang L, Ma Z, Yang W, Guo X, Huang C, Cui Z, Sun F, Song D, Liu L, Tao L. Novel biomarkers identifying hypertrophic cardiomyopathy and its obstructive variant based on targeted amino acid metabolomics. Chin Med J (Engl). 2022;135(16):1952\u201361.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"768_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000497748","volume":"9","author":"GM Virz\u00ec","year":"2019","unstructured":"Virz\u00ec GM, Clementi A, Battaglia GG, Ronco C. Multi-Omics approach: new potential key mechanisms implicated in cardiorenal syndromes. Cardiorenal Med. 2019;9(4):201\u201311.","journal-title":"Cardiorenal Med"},{"key":"768_CR8","doi-asserted-by":"crossref","unstructured":"Zhao B-R, Hu X-R, Wang W-D, Zhou Y. Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies. Acta Pharmacol Sin. 2025;0:1\u201317.","DOI":"10.1038\/s41401-025-01476-z"},{"issue":"3","key":"768_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000524722","volume":"78","author":"I Ampong","year":"2022","unstructured":"Ampong I. Metabolic and metabolomics insights into dilated cardiomyopathy. Ann Nutr Metab. 2022;78(3):147\u201355.","journal-title":"Ann Nutr Metab"},{"issue":"11","key":"768_CR10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3390\/metabo12111068","volume":"12","author":"M Xu","year":"2022","unstructured":"Xu M, Cui H, Chen X, Hua X, Song J, Hu S. Changes of plasma Tris(hydroxymethyl)aminomethane and 5-Guanidino-3-methyl-2-oxopentanoic acid as biomarkers of heart remodeling after left ventricular assist device support. Metabolites. 2022;12(11):1068.","journal-title":"Metabolites"},{"key":"768_CR11","doi-asserted-by":"crossref","first-page":"155977","DOI":"10.1016\/j.metabol.2024.155977","volume":"158","author":"S Shu","year":"2024","unstructured":"Shu S, Cui H, Liu Z, Zhang H, Yang Y, Chen X, Zeng Z, Du L, Fu M, Yang Z, Wang P, Wang C, Gao H, Yang Q, Lin X, Yang T, Chen Z, Wu S, Wang X, Zhao R, Hu S, Song J. Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy. Metab Clin Exp. 2024;158:155977.","journal-title":"Metab Clin Exp"},{"issue":"530","key":"768_CR12","doi-asserted-by":"crossref","first-page":"eaay8329","DOI":"10.1126\/scitranslmed.aay8329","volume":"12","author":"J-P Song","year":"2020","unstructured":"Song J-P, Chen L, Chen X, Ren J, Zhang N-N, Tirasawasdichai T, Hu Z-L, Hua W, Hu Y-R, Tang H-R, Chen H-SV, Hu S-S. Elevated plasma \u03b2-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy. Sci Transl Med. 2020;12(530):eaay8329.","journal-title":"Sci Transl Med"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00768-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T15:05:52Z","timestamp":1743865552000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00768-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00768-0","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fuwai Hospital and carried out in accordance with the Helsinki Declaration of 1964. The individuals who took part in this study provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved this manuscript and affirm that it has not been previously published nor is it under consideration by another journal. Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors disclose no competing financial conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}